NCT06400550Recruiting
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
The goal of this study is to observe metabolic features associated with human melanoma tumors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 1 May 2024
- Start date
- 1 Aug 2018
- Primary completion date
- 1 Aug 2028
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- Melanoma
- NCT number
- NCT06400550
What you commit to
- Study type: Observational
- Planned participants: 400
- From 1 Aug 2018 to the primary completion date, 1 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not a surgical candidate
Other illness
- Poorly controlled diabetes
Who the study is looking for
- Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision.
- Subjects of all races and ethnic origins over age 18.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.